← All trials
NCT05940194
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 11, 2021
- Primary completion
- Oct 18, 2021
- Completion date
- Mar 11, 2022
- First posted
- Jul 11, 2023
- Last posted
- Jul 14, 2023
- Enrollment
- 374
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Institute of Vaccines and Medical Biologicals, VietnamLead sponsor
- Government of VietnamCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.